Hunan Creator Information Technologies
300730
Shandong Rike Chemical
300214
Jiangsu LiXing General Steel Ball
300421
4
Jiangsu Boiln Plastics
301003
5
Ningbo Henghe Precision Industry
300539
US Stock MarketDetailed Quotes
OTLK Outlook Therapeutics
- 1.480
- -0.040-2.63%
Close Feb 25 16:00 ET
- 1.630
- +0.150+10.14%
Post 20:01 ET
47.39MMarket Cap-0.60P/E (TTM)
1.540High1.441Low412.07KVolume1.540Open1.520Pre Close612.30KTurnover1.75%Turnover RatioLossP/E (Static)32.02MShares12.85052wk High-0.94P/B34.92MFloat Cap0.87052wk Low--Dividend TTM23.60MShs Float219.200Historical High--Div YieldTTM6.55%Amplitude0.870Historical Low1.485Avg Price1Lot Size
Outlook Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 15.84%-10.97M | -60.08%-68.79M | -33.28%-16.98M | -47.64%-19.51M | -137.44%-19.27M | -46.41%-13.03M | 24.18%-42.97M | -24.30%-12.74M | 37.36%-13.22M | 43.39%-8.11M |
| Net income from continuing operations | 255.46%17.38M | -27.78%-75.37M | 143.81%5.69M | 314.80%44.41M | -1,617.52%-114.29M | 40.10%-11.18M | 10.70%-58.98M | 9.44%-12.99M | -17.87%-20.68M | 66.23%-6.65M |
| Operating gains losses | -79,321.14%-40.24M | -294.76%-1.05M | -529,695.72%-28.84M | -295,839.99%-56M | 5,075,432.12%83.74M | -90.34%50.79K | -11.61%537.74K | -37.62%-5.44K | 108.69%18.94K | -105.31%-1.65K |
| Depreciation and amortization | 2.15%28.8K | 157.67%113.86K | 156.73%28.8K | 156.18%28.67K | 156.29%28.2K | 161.60%28.2K | -78.41%44.19K | -78.21%11.22K | -78.17%11.19K | -78.47%11K |
| Other non cash items | 31.32%1.3M | 95.58%2.68M | --0 | --0 | --1.69M | -27.58%993K | -45.98%1.37M | --0 | --0 | --0 |
| Change In working capital | 264.09%6.89M | -163.49%-3.02M | 312.25%4.22M | -156.72%-1.78M | 55.84%-1.26M | -164.98%-4.2M | 382.19%4.75M | -189.78%-1.99M | 156.28%3.14M | -474.19%-2.86M |
| -Change in inventory | ---3.11M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Change in prepaid assets | 330.36%5.63M | -287.29%-4.9M | -38.27%1.1M | -2,764.49%-3.04M | -595.95%-524.12K | -410.12%-2.45M | 184.61%2.62M | 30.80%1.79M | 103.38%113.96K | 90.67%-75.31K |
| -Change in payables and accrued expense | 349.71%4.38M | -20.47%1.89M | 181.20%3.09M | -60.65%1.28M | 73.60%-731.16K | -130.84%-1.75M | 63.40%2.37M | -543.20%-3.8M | 248.51%3.26M | -275.18%-2.77M |
| -Change in other current assets | ---- | 97.17%-5.9K | -4.38%22.97K | 90.11%-22.97K | ---- | ---- | ---208.2K | --24.02K | ---232.22K | ---- |
| -Change in other current liabilities | ---- | 112.64%3.41K | --5.63K | 43.50%-2.22K | ---- | ---- | 37.01%-27K | --0 | 63.94%-3.93K | -11.06%-11.64K |
| -Change in other working capital | ---12.07K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 15.84%-10.97M | -60.08%-68.79M | -33.28%-16.98M | -47.64%-19.51M | -137.44%-19.27M | -46.41%-13.03M | 24.18%-42.97M | -24.30%-12.74M | 37.36%-13.22M | 43.39%-8.11M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 54,839.96%1.74M | 23.20%60.33M | -104.74%-114.95K | 30.69%4.31M | 9,501.66%56.14M | -100.01%-3.18K | -17.83%48.97M | 49.08%2.42M | 129.16%3.3M | -122.90%-597.13K |
| Net issuance payments of debt | --0 | -100.02%-4.27K | --0 | --0 | 62.48%-1.08K | -100.02%-3.18K | 952.41%19.77M | 45.79%-3.08K | 99.97%-2.98K | 99.06%-2.89K |
| Net common stock issuance | --1.74M | 100.95%60.33M | -104.74%-114.95K | 30.57%4.31M | 16,647.34%56.14M | --0 | -51.81%30.02M | 48.75%2.43M | 1,025.98%3.3M | -112.44%-339.28K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | -37.32%-823.89K | --0 | --0 | ---254.96K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 54,839.96%1.74M | 23.20%60.33M | -104.74%-114.95K | 30.69%4.31M | 9,501.66%56.14M | -100.01%-3.18K | -17.83%48.97M | 49.08%2.42M | 129.16%3.3M | -122.90%-597.13K |
| Net cash flow | ||||||||||
| Beginning cash position | -36.19%14.93M | 34.46%23.39M | -5.00%32.02M | 8.25%47.23M | -80.21%10.36M | 34.46%23.39M | 20.17%17.4M | 29.54%33.71M | -25.32%43.63M | -25.39%52.34M |
| Current changes in cash | 29.23%-9.22M | -241.19%-8.46M | -65.71%-17.1M | -53.27%-15.2M | 523.25%36.87M | -137.30%-13.04M | 105.35%6M | -19.62%-10.32M | 69.39%-9.92M | 25.71%-8.71M |
| End cash Position | -44.94%5.7M | -36.19%14.93M | -36.19%14.93M | -5.00%32.02M | 8.25%47.23M | -80.21%10.36M | 34.46%23.39M | 34.46%23.39M | 29.54%33.71M | -25.32%43.63M |
| Free cash flow | 15.84%-10.97M | -60.08%-68.79M | -33.28%-16.98M | -47.64%-19.51M | -137.44%-19.27M | -46.41%-13.03M | 24.18%-42.97M | -24.30%-12.74M | 37.36%-13.22M | 43.39%-8.11M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Trending Stocks
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum
Moo Earnings
Jan 24 10:26
TSLA earnings preview: Grab rewards by guessing the opening price!